Pfizer, Wyeth to merge under single brand

Last Updated: Saturday, November 23, 2013, 20:02

The Board of Directors of Pfizer Ltd and Wyeth Ltd, in their respective meetings today, approved a proposal to merge Wyeth India with Pfizer India, Pfizer said in a statement.

Sun Pharma to pay Rs 2,517 cr to settle patent suit

Last Updated: Sunday, August 11, 2013, 14:49

Drug firm Sun Pharmaceutical Industries has said it will pay its dues of Rs 2,517.41 crore soon as part of settlement agreement with Wyeth (now a division of Pfizer Inc.) and Altana Pharma AG (now known as Takeda GmbH).

US fines Wyeth $490.9 mn for illegal drug marketing

Last Updated: Wednesday, July 31, 2013, 09:39

Wyeth was acquired by US drug giant Pfizer in 2009.

Pfizer, Boeing, other US firms lobbying hard on Indian issues

Last Updated: Monday, July 29, 2013, 19:16

At least two dozen American companies and industry groups are lobbying hard with the US lawmakers on issues related to their Indian business interests and bilateral trade issues between the two countries, even as retail giant Walmart has halted such activities.

Sun Pharma stocks tank nearly 7% in early trade

Last Updated: Thursday, June 13, 2013, 13:36

Shares of Sun Pharmaceuticals on Thursday fell sharply by nearly 7 percent in early trade, after the pharmaceutical major and Israel's Teva agreed to pay a sum of USD 2.15 billion to Pfizer and Takeda as part of patent infringement settlement.

Sun Pharma, Teva to pay $2.15 bn to Pfizer, Takeda

Last Updated: Wednesday, June 12, 2013, 20:39

India's Sun Pharmaceuticals and Israel's Teva will pay a sum of USD 2.15 billion to Pfizer and Takeda as part of patent infringement settlement for acid reflux medicine Protonix in the US.

Boeing, Pfizer, Dow among US entities lobbying on India issues

Last Updated: Sunday, April 21, 2013, 14:51

At least a dozen US-based entities, including giants like Boeing, Pfizer, Dow Chemicals and Morgan Stanley, have indulged in lobbying among the American lawmakers here regarding India-related trade issues since the beginning of this year.

Pfizer files patent suit against Lupin, 5 other pharma firms

Last Updated: Tuesday, March 5, 2013, 23:09

US-based pharma giant Pfizer Inc on Tuesday said it has filed suit against six firms, including India's Lupin, over patent infringement of celecoxib, the active ingredient of its branded drug Celebrex used for treating osteoarthritis.

Pfizer posts Q3 net profit at Rs 63.88 crore

Last Updated: Friday, February 8, 2013, 14:32

Drug firm Pfizer on Friday reported a net profit of Rs 63.88 crore for the quarter ended December 31, 2012.

Pfizer posts net profit of Rs 52 cr in Q2

Last Updated: Thursday, November 8, 2012, 22:25

Drug firm Pfizer Thursday posted net profit of Rs 52.28 crore for the second quarter ended September 30.

Pfizer to challenge patent revocation of cancer drug Sutent

Last Updated: Friday, October 5, 2012, 17:42

The Indian Patents Office last month issued an order revoking Pfizer's patent of the drug in the country.

CCI approves Nestle's acquisition of Pfizer Nutrition

Last Updated: Wednesday, August 8, 2012, 20:05

In April, Nestle had said that it would acquire Pfizer Inc's infant nutrition business for USD 11.85 billion, a move that will enhance Swiss food giant's position in emerging markets.